about
Stability-indicating HPTLC method for quantitative estimation of silybin in bulk drug and pharmaceutical dosage form.Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.Cyclodextrins in drug delivery: an updated reviewBuccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation.Exploring scientifically proven herbal aphrodisiacsDevelopment and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.Patents on nanoparticulate drug delivery systems--a review.Potential of microemulsions in drug delivery and therapeutics: a patent review.Site specific chronotherapeutic drug delivery systems: a patent review.Recent advances in pelletization technique for oral drug delivery: a review.Status of novel drug delivery technology for phytotherapeutics.Herbal remedies for the treatment of periodontal disease--a patent review.Chronopharmaceutics: a promising drug delivery finding of the last two decades.Strategy for effective brain drug delivery.Patented herbal formulations and their therapeutic applications.Neurotherapeutic applications of nanoparticles in Alzheimer's disease.New non-oral drug delivery systems for Parkinson's disease treatment.Exploring novel approaches to vaginal drug delivery.Recent advances and patents in solid dispersion technology.Nanostructure-based drug delivery systems for brain targeting.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.Nanostructured lipid carriers system: recent advances in drug delivery.Potentials and challenges in self-nanoemulsifying drug delivery systems.Oral delivery of therapeutic proteins and peptides: a review on recent developments.Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion.Box-Behnken supported validation of stability-indicating high performance thin-layer chromatography (HPTLC) method: An application in degradation kinetic profiling of ropinirole.Formulation and development of floating capsules of celecoxib: in vitro and in vivo evaluationFormulation and Evaluation of Tramadol hydrochloride Rectal Suppositories.Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate.Development and in vitro Evaluation of Enteric Coated Multiparticulate System for Resistant Tuberculosis.Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma.Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation.Targeted retentive device for oro-dental infections: formulation and development.Development of HPTLC method for the estimation of ondansetron hydrochloride in bulk drug and sublingual tablets.Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations.UHPLC/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: a comparative effects of intranasal administration of ropinirole solution over nanoemulsion.
P50
Q33509543-49181478-2493-450E-9C1F-A0AE0CD62D3EQ33756624-EE55DAD7-AF72-48E5-9EC5-B95C27394BA4Q34563402-5EF906EB-D737-44DE-B3E3-B9A6AB7A6D6BQ34628744-6900CFE4-87A3-4859-AD29-4622F2300B08Q34655086-2E6B3151-2DB7-4C4C-B074-DB7E5425C19DQ35042958-4E9D035D-F55A-4028-BB69-E4A655E451E7Q35153612-1FEDEB47-7ACA-4728-9035-107112AFC6DBQ37347845-C296DF4A-4491-4229-96BE-28A1B31705B6Q37347862-427C5CC7-16F3-434A-BC65-3F1111BDC478Q37370750-20AF824E-F776-4407-8E2B-2B46CE9BD1B4Q37471975-798D271B-3E34-44E2-9E6A-874CD63E22DAQ37510870-CCE3C95E-7E1D-4B80-859E-6282A89806BEQ37635265-FE2623EF-B229-4BFB-AEC5-5C27CF7CCA5BQ37692504-FCD8473C-147E-47F5-9CE2-308A0B72BB34Q37760347-02B1B76D-BE85-4CAE-B53A-8FA2B8A9645FQ37772178-2F8F8436-E07E-4E58-879A-687A7E896FA5Q37816572-CE31BF1B-6D51-41E5-B9DC-4DCB8700718FQ37840165-CB905FF5-7079-40B1-AE92-73C151959CD6Q37854076-0F185590-24FE-49B8-9BC5-717681942CF8Q37915575-2266BAEA-03C4-4D0A-AAC9-4E0B6E97EC92Q37939942-0C6DA21F-9B19-4B66-9E19-99D3717860CFQ37948993-768E14F4-1869-4899-8942-B1EB3E1A0C18Q38003473-36B287F4-5C44-4902-A80E-720E265560DEQ38038902-85DF97BF-1264-413B-B840-DA7A0269ADB3Q38041256-2042B103-68D4-413C-B74E-7AAF16B872C6Q38122734-B6C0472C-A690-4D39-847A-F83717175683Q40818255-748E4ED8-1345-4707-B9A0-2895DD4D9FEEQ41963500-15E88932-5CF8-4D23-8C84-EF1969287B26Q41989907-1D064976-8563-4477-885A-0BADF67D09B8Q42599226-E46A4956-46F8-4C68-BB6E-B7631AD419F5Q42740955-E99FB1A6-0FC2-4AD4-B359-EEB1B1CA8A94Q42954821-04782EDC-9570-42AF-9938-7F14E466D6D3Q42954901-DBB8F788-4A70-4184-B4E4-09E4CB253D05Q43196457-3B5A3895-E5C1-4D01-B7E0-B02C7469E5F2Q43883374-955F2401-1901-41F0-971A-74BF7B156E11Q44466021-B7F26751-29A2-4F04-8ED9-5D7F5896F8F2Q44966173-56B4891C-1AD0-4FE3-B690-D01DA39C8F59Q46388069-D37DD5E7-29F1-4FFC-A57F-1F0333FE28DDQ46533034-2447AC68-ADA1-4916-8EC9-D258CC0A0B8DQ46580014-A9292700-3C7C-4F40-B1D7-720B477E4219
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Javed Ali
@ast
Javed Ali
@en
Javed Ali
@es
Javed Ali
@nl
Javed Ali
@sl
জাভেদ আলী
@bn
type
label
Javed Ali
@ast
Javed Ali
@en
Javed Ali
@es
Javed Ali
@nl
Javed Ali
@sl
জাভেদ আলী
@bn
prefLabel
Javed Ali
@ast
Javed Ali
@en
Javed Ali
@es
Javed Ali
@nl
Javed Ali
@sl
জাভেদ আলী
@bn
P1053
S-3180-2017
P106
P1153
25641028400
P31
P3829
P496
0000-0001-5308-0655
P569
2000-01-01T00:00:00Z